EGFR and cancer: Our data, along with previous research, demonstrating that activation of MAPK pathways promote survival of cancer cells (27) suggest that co-culture with fibroblasts partially abrogates the gefitinib-induced inhibitory effect of downstream molecules in an EGFR-independent manner in HCC827 cells.